Erik Nilsson

Erik Nilsson is president of Seattle-based Insilicos, a biotech company developing diagnostics for cardiovascular disease. A serial entrepreneur, he has participated in two startups at the executive level and a couple more as a worker bee. Erik is currently principal investigator on three NIH grants related to Insilicos' work. He is an active member of the Washington Biotechnology and Biomedical Association.

Erik lives happily in Seattle with his family. When not at work, he can be found riding bicycle ultramarathons, collecting Northwest Coast Indian art, or building strange scientific instruments with his son. He can sail a boat, build a bicycle wheel, decipher a letter in Swedish, and do any kind of house wiring.

Recent posts and comments

• Seattle’s Growing Advantage in The Cloud

  Cloud computing and biotech are the two most important nonlinearly-growing economic sectors. These two sectors intersect in Seattle in a unique way that has important implications for all involved. Small changes now... Read more »

• Hard Work is Essential for Startups. But How Much is Too Much? (Part 2)

  Yesterday, I talked a little about balancing short and long-term effort at a startup. Today, I want to discuss “cranking,” which I’ll define as a short-run effort to achieve an extremely important short-term goal.

  How... Read more »

• Hard Work Is Essential for Startups. But How Much is Too Much? (Part 1)

  Xconomy has seen a vigorous discussion of work/life balance in Seattle. Is Seattle slack compared to the San Francisco Bay Area? If so, does the difference matter? Janis Machala of UW TechTransfer... Read more »